Literature DB >> 16261400

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

Marcela Gallardo1, Antonia Silva, Lorena Rubio, Carolina Alvarez, Carolina Torrealba, Mauricio Salinas, Teresa Tapia, Paola Faundez, Lorena Palma, María Eugenia Riccio, Hernando Paredes, Mario Rodriguez, Adolfo Cruz, Christine Rousseau, Mary Claire King, Mauricio Camus, Manuel Alvarez, Pilar Carvallo.   

Abstract

Our aim was to analyze the incidence of mutations in BRCA1 and BRCA2 genes in 54 families with breast/ovarian cancer. Families were selected from three Institutions following the standard criteria for hereditary breast/ovarian cancer. PCR amplification of all exons was performed, followed by SSCP, heteroduplex, PTT and sequencing analysis. We identified eight truncation mutations, three in the BRCA1 gene and five in the BRCA2 gene. Three of these mutations have not been reported previously by other groups: 308insA in one family, 3936 C>T in two families, for BRCA1, and 4970insTG in one family for BRCA2. In addition two families having Ashkenazi Jewish ancestors present the well known mutations 185delAG and 6174delT. Interestingly, 5 out of 11 families have mutations recurrent in Spanish families. Among the 54 families selected, seven have breast and ovary cancer cases, and only two presented a mutation in BRCA1 or BRCA2 genes. Other cancers as prostate and stomach are frequent among relatives carrying the mutation. Five cases of very early onset (<31 years old) breast cancer were detected. The frequencies of BRCA1 (0.074) and BRCA2 (0.13) mutations in our families is low but similar to the incidence found in other populations, like in Spain. Since is widely known that risk factors that modulate the development of breast cancer such as lifestyle risk factors, geographic location, country of origin and socioeconomic status, besides a familial history of breast cancer our findings suggest that the history of colonization and immigrations is very relevant when studying hereditary factors associated to breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16261400     DOI: 10.1007/s10549-005-9047-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

1.  Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.

Authors:  J Abugattas; M Llacuachaqui; Y Sullcahuaman Allende; A Arias Velásquez; R Velarde; J Cotrina; M Garcés; M León; G Calderón; M de la Cruz; P Mora; R Royer; J Herzog; J N Weitzel; S A Narod
Journal:  Clin Genet       Date:  2014-10-28       Impact factor: 4.438

2.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

3.  Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Authors:  Cynthia Villarreal-Garza; Rosa María Alvarez-Gómez; Carlos Pérez-Plasencia; Luis A Herrera; Josef Herzog; Danielle Castillo; Alejandro Mohar; Clementina Castro; Lenny N Gallardo; Dolores Gallardo; Miguel Santibáñez; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

Review 4.  Familial Gastric Cancers.

Authors:  Namrata Setia; Jeffrey W Clark; Dan G Duda; Theodore S Hong; Eunice L Kwak; John T Mullen; Gregory Y Lauwers
Journal:  Oncologist       Date:  2015-09-30

5.  Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

Authors:  Julie Dutil; Jose L Colon-Colon; Jaime L Matta; Rebecca Sutphen; Miguel Echenique
Journal:  Cancer Genet       Date:  2012-05

6.  The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.

Authors:  C Villarreal-Garza; J N Weitzel; M Llacuachaqui; E Sifuentes; M C Magallanes-Hoyos; L Gallardo; R M Alvarez-Gómez; J Herzog; D Castillo; R Royer; Mohammad Akbari; F Lara-Medina; L A Herrera; A Mohar; S A Narod
Journal:  Breast Cancer Res Treat       Date:  2015-02-26       Impact factor: 4.872

Review 7.  Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Authors:  Yanin Chavarri-Guerra; Kathleen Reilly Blazer; Jeffrey Nelson Weitzel
Journal:  Rev Invest Clin       Date:  2017 Mar-Apr       Impact factor: 1.451

8.  Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba.

Authors:  Rolando Comacho Rodriguez; Antonio Alejandro Esperon; Ramon Ropero; Maria Caridad Rubio; Ronald Rodriguez; Rosa M Ortiz; Juan J Lence Anta; Mario de los Rios; Deyanira Carnesolta; Maria C del Olivera; Somalia Stiu Vansam; Robert Royer; Mohammad R Akbari; Talia Donenberg; Steven A Narod
Journal:  Fam Cancer       Date:  2008-02-20       Impact factor: 2.375

Review 9.  The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Authors:  Elaine A Ostrander; Miriam S Udler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 10.  Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

Authors:  Carlos Andrés Ossa; Diana Torres
Journal:  Oncologist       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.